Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab

被引：0
|
作者：
Jessica R. Allegretti
Edward L. Barnes
Betsey Stevens
Margaret Storm
Ashwin Ananthakrishnan
Vijay Yajnik
Joshua Korzenik
机构：
[1] Brigham and Women’s Hospital,Division of Gastroenterology
[2] Massachusetts General Hospital,Gastroenterology Unit
[3] Harvard Medical School,undefined
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Vedolizumab; Combination therapy; Immunomodulator; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1590 / 1596
页数：6
相关论文
共 50 条
  • [1] Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Allegretti, Jessica R.
    Barnes, Edward L.
    Stevens, Betsey
    Storm, Margaret
    Ananthakrishnan, Ashwin
    Yajnik, Vijay
    Korzenik, Joshua
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1590 - 1596
  • [2] Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
    Martin, Antoine
    Nachury, Maria
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Nancey, Stephane
    Bourrier, Anne
    Serrero, Melanie
    Fumery, Mathurin
    Buisson, Anthony
    Laharie, David
    Gilletta, Cyrielle
    Filippi, Jerome
    Allez, Matthieu
    Bouguen, Guillaume
    Roblin, Xavier
    Altwegg, Romain
    Dib, Nina
    de Chambrun, Guillaume Pineton
    Savoye, Guillaume
    Carbonnel, Franck
    Viennot, Stephanie
    Amiot, Aurelien
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07) : 896 - 903
  • [3] Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
    Shmidt, Eugenia
    Kochhar, Gursimran
    Hartke, Justin
    Chilukuri, Prianka
    Meserve, Joseph
    Chaudrey, Khadija
    Koliani-Pace, Jenna L.
    Hirten, Robert
    Faleck, David
    Barocas, Morris
    Luo, Michelle
    Lasch, Karen
    Boland, Brigid S.
    Singh, Siddharth
    Vande Casteele, Niels
    Sagi, Sashidhar Varma
    Fischer, Monika
    Chang, Shannon
    Bohm, Matthew
    Lukin, Dana
    Sultan, Keith
    Swaminath, Arun
    Hudesman, David
    Gupta, Nitin
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Siegel, Corey A.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Shen, Bo
    Dulai, Parambir S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2461 - 2467
  • [4] Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Pernes, Tyler
    Weiss, Alexandra
    Trivedi, Chinmay
    Patel, Manthankumar
    Medvedeva, Elina
    Xie, Dawei
    Yang, Yu-Xiao
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 734 - 744
  • [5] The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Abraham, Bincy P.
    Fan, Christopher
    Thurston, Theresa
    Moskow, Joshua
    Malaty, Hoda M.
    NUTRIENTS, 2023, 15 (22)
  • [6] Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab
    Zimmerman, Lori A.
    Zalieckas, Jill M.
    Shamberger, Robert C.
    Bousvaros, Athos
    JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (07) : 1330 - 1333
  • [7] Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Nocturne, Gaetane
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    RHEUMATOLOGY, 2020, 59 (11) : 3275 - 3283
  • [8] Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
    De Vos, Martine
    Dhooghe, Barbara
    Vermeire, Severine
    Louis, Edouard
    Mana, Fazia
    Elewaut, Ann
    Bossuyt, Peter
    Baert, Filip
    Reenaers, Catherine
    Van Gossum, Marc
    Macken, Elisabeth
    Ferrante, Marc
    Hindryckx, Pieter
    Dewit, Olivier
    Holvoet, Tom
    Franchimont, Denis
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (03) : 439 - 445
  • [9] Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study
    Cohen, Nathaniel Aviv
    Plevris, Nikolas
    Kopylov, Uri
    Grinman, Anna
    Ungar, Bella
    Yanai, Henit
    Leibovitzh, Haim
    Isakov, Naomi Fliss
    Hirsch, Ayal
    Ritter, Einat
    Ron, Yulia
    Shitrit, Ariella Bar-Gil
    Goldin, Eran
    Dotan, Iris
    Ben Horin, Shomron
    Lees, Charlie W.
    Maharshak, Nitsan
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (09) : 1076 - 1085
  • [10] Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study
    Lightner, Amy L.
    Mathis, Kellie L.
    Tse, Chung Sang
    Pemberton, John H.
    Shen, Bo
    Kochlar, Gursimran
    Singh, Amandeep
    Dulai, Parambir S.
    Eisenstein, Samuel
    Sandborn, William J.
    Parry, Lisa
    Stringfield, Sarah
    Hudesman, David
    Remzi, Feza
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 871 - 876
12345